You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 2, February 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuropathological Correlates of Dysarthria in Progressive Supranuclear Palsy

Karen J. Kluin, MS, CCC, BC-NCD; Sid Gilman, MD; Norman L. Foster, MD; Anders A. F. Sima, MD, PhD; Constance J. D'Amato, BS; Leslie A. Bruch, MD; Laurie Bluemlein, RN, MS; Roderick Little, PhD; Jewel Johanns, PhD

Arch Neurol. 2001;58:265-269.

Background  The dysarthria of progressive supranuclear palsy consists of prominent hypokinetic and spastic components with less prominent ataxic components.

Objective  To correlate the types of dysarthria with neuropathological changes in patients with progressive supranuclear palsy.

Design and Methods  In 14 patients with progressive supranuclear palsy, we correlated the perceptual speech findings with the neuropathological findings. A dysarthria assessment was performed a mean ± SD of 31 ± 15 months (range, 10-53 months) before death. The deviant speech dimensions were rated on a scale of 0 (normal) to 3 (severe). The neuropathological examination consisted of semiquantitative analysis of neuronal loss and gliosis by investigators (A.A.F.S., and L.A.B.) blinded to the clinical findings. Correlation and linear regression analysis were used to correlate the severity of the hypokinetic, spastic, and ataxic components with the degree of neuronal loss and gliosis in predetermined anatomical sites.

Results  All patients had hypokinetic and spastic dysarthria, and 9 also had ataxic components. The severity of the hypokinetic components was significantly correlated with the degree of neuronal loss and gliosis in the substantia nigra pars compacta (r = 0.61, P = .02) and pars reticulata (r = 0.64, P = .01) but not in the subthalamic nucleus (r = 0.51, P = .07) or the striatum or globus pallidus (/r/<0.34, P>.20). The severity of the spastic and ataxic components was not significantly correlated with the neuropathological changes in the frontal cortex (r = 0.20, P = .50) and cerebellum (/r/<0.28, P>.33), respectively.

Conclusion  The hypokinetic dysarthria of progressive supranuclear palsy may result from degenerative changes in the substantia nigra pars compacta and pars reticulata and not from changes in the striatum or globus pallidus.


From the Departments of Speech-Language Pathology (Ms Kluin), Neurology (Mss Kluin and Bluemlein and Drs Gilman and Foster), Pathology (Dr Sima and Ms D'Amato), and Biostatistics (Drs Little and Johanns), University of Michigan Health System, Ann Arbor; the Department of Pathology, Wayne State University, Detroit, Mich (Dr Sima); and the Department of Pathology and Microbiology, University of Nebraska, Omaha (Dr Bruch).

Corresponding author and reprints: Karen J. Kluin, MS, CCC, BC-NCD, Department of Speech-Language Pathology, University of Michigan Health System, 1D203 University Hospital, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0043.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuropathologic Correlates of Dysarthria in Progressive Supranuclear Palsy
Jellinger et al.
Arch Neurol 2001;58:1499-1500.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.